Skip to main content
PLEASE NOTE: For everyone’s safety, Fasken requires anyone on-site at our Canadian offices to provide proof of full vaccination against COVID-19. This applies to lawyers, staff, clients, service providers and other visitors.
Client Work

Terramera raises US$45 million Series B financing led by Ospraie Ag Science and Seed2Growth

Reading Time 1 minute read Subscribe


Terramera is an emerging cleantech leader with revolutionary technologies to transform how we grow food.
Terramera raised US$45 million in equity funding to advance its Actigate™ Targeted Performance technology. The close of this Series B round was led by new investor Ospraie Ag Science and previous investor Seed2Growth (“S2G”) Ventures. The funds raised will enable Terramera to scale its technology and transform agriculture while positively impacting the environment and the well-being of people worldwide.

Terramera are on the cutting edge of Agri business technology. Fasken has a longstanding relationship with Terramara and understands the details of their business to provide effective legal services including on the equity financing in this matter where Fasken advised in negotiation and implementation of this transaction.
Terramera was represented by a team that included Geoff Pedlow, Shahrooz Nabavi, Keith Spencer, Cathy Jares and Reina Mistry.


    Receive email updates from our team